IL18RAP and central nervous system cancer: The remaining genes (IL-1α, CXCL7, IL-18RAP, CCL3) have not been well-studied in glioma, with the exception of CCL3, which is shown to improve the response to dendritic cell vaccines of patients with GBM (107).